Kezar Life Sciences, Inc. Common Stock
KZR
XNAS
•
PHARMACEUTICAL PREPARATIONS
Market Cap
54M
Short interest (Apr 15)
2.1%
Net Short (May 08 ): 0.0%
Borrow Fee
0.41%
Available Shares
0
Price Chart
Company Overview
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Company Info
Exchange:
NASDAQ
Industry:
PHARMACEUTICAL PREPARATIONS
CIK:
0001645666
Asset Type:
CS
Market Data
Market Cap:
$53,856,340
Employees:
9
Status:
Active
Short Interest
Current Borrow Fee
0.41%
Range: 0.41% -
0.41%
Available Shares
0
Range: 0 -
0
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.